TAKEDA DEVELOPMENT CENTRE EUROPE LTD.
Company Information
- Company Number
- 03638034
- Registered Address
- 1 Kingdom Street, London, England, W2 6BD
- Status
- Active
- Employee Count
- 1
- Turnover
- £295,893
- EBITDA
- £117,000
Additional Details
- Website
- https://takeda.co.uk
- Company Type
- Private limited Company
- Incorporated On
- 21 September 1998
- Nature of Business
- 72190 - Other research and experimental development on natural sciences and engineering
- Industries
- Professional Services
- Region
- London
Time to Pay
Payment Timeline
Payment Features
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Oct 2018 - 31 Mar 2019 | 03 Oct 2019 | 32 | 68% | 11% | 21% | 7% |
| 01 Apr 2018 - 30 Sept 2018 | 30 Oct 2018 | 28 | 69% | 22% | 9% | 22% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
The majority of suppliers are subject to local standard terms of purchase or qualify as small medium businesses and are subject to standard payment terms of 30 or 45 days from receipt of a valid invoice. Global and larger local suppliers with negotiated contracts are subject to standard payment terms of up to 90 days from receipt of a valid invoice
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
90
Dispute Resolution Process
Disputes related to payment are generally resolved informally by discussion between the relevant parties
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
Takeda Development Centre Europe Ltd. is a leading pharmaceutical company with a strong focus on sustainability and innovation. Established in 2004, the company is headquartered in London, UK and is a subsidiary of Takeda Pharmaceutical Company Limited.
The company's main activities include the development and commercialization of innovative medicines to improve the health and wellbeing of people around the world. Takeda Development Centre Europe Ltd. is committed to sustainability and has implemented various initiatives to reduce their environmental impact, such as reducing waste and investing in renewable energy sources. They also prioritize ethical business practices and have a strict code of conduct in place.
Takeda Development Centre Europe Ltd. has a diverse portfolio of products and services, ranging from prescription drugs to consumer healthcare products. They focus on therapeutic areas such as oncology, gastroenterology, neuroscience, and rare diseases. The company's mission is to provide patients with innovative, safe, and effective treatments that improve their quality of life.
The key people at Takeda Development Centre Europe Ltd. include Christophe Weber, the President and CEO of Takeda Pharmaceutical Company Limited, and Giles Platford, the President of Takeda Europe and Canada. They lead a team of experienced professionals who are dedicated to advancing the company's mission and values.
For more information on the company's products, services, and sustainability efforts, visit their website at www.takeda.com. Their registered office address is 1-2 Kingdom Street, London, W2 6BD, United Kingdom. Takeda Development Centre Europe Ltd. continues to be a leader in the pharmaceutical industry, committed to making a positive impact on both patients and the environment.
